Medoz Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 6.21 M
- Company Age 25 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.26 Cr
- Satisfied Charges ₹ 4.98 Cr
- Revenue Growth 30.93%
- Profit Growth -20.27%
- Ebitda 43.49%
- Net Worth 6.49%
- Total Assets -7.24%
About Medoz Pharmaceuticals
Medoz Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 February 2000 and has a history of 25 years. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.21 M.
The company currently has active open charges totaling ₹7.26 Cr. The company has closed loans amounting to ₹4.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Agrawal and Parmar Rameshkumar serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ2000PTC037288
- Company No.
037288
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Medoz Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Agrawal  | Managing Director | 02-Feb-2000 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parmar Rameshkumar | Director | 18-Sep-2019 | Current |
Financial Performance of Medoz Pharmaceuticals.
Medoz Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.93% increase. The company also saw a substantial fall in profitability, with a 20.27% decrease in profit. The company's net worth moved up by a moderate rise of 6.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medoz Pharmaceuticals?
In 2021, Medoz Pharmaceuticals had a public holding of 26.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.26 Cr
₹4.98 Cr
Charges Breakdown by Lending Institutions
- Others : 6.79 Cr
- Director Of Industries Himachal Pradesh : 0.30 Cr
- Canara Bank : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2024 | Others | ₹1.96 M | Open |
| 02 Nov 2020 | Canara Bank | ₹1.70 M | Open |
| 25 Sep 2019 | Others | ₹6.60 Cr | Open |
| 21 Feb 2011 | Director Of Industries Himachal Pradesh | ₹3.00 M | Open |
| 09 Mar 2021 | Hdfc Bank Limited | ₹3.39 Cr | Satisfied |
How Many Employees Work at Medoz Pharmaceuticals?
Medoz Pharmaceuticals has a workforce of 38 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medoz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medoz Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
